These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8468253)

  • 1. Mer-WF3010, a new member of the papulacandin family. II. Structure determination.
    Chiba H; Kaneto R; Agematu H; Shibamoto N; Yoshioka T; Nishida H; Okamoto R
    J Antibiot (Tokyo); 1993 Feb; 46(2):356-8. PubMed ID: 8468253
    [No Abstract]   [Full Text] [Related]  

  • 2. Mer-WF3010, a new member of the papulacandin family. I. Fermentation, isolation and characterization.
    Kaneto R; Chiba H; Agematu H; Shibamoto N; Yoshioka T; Nishida H; Okamoto R
    J Antibiot (Tokyo); 1993 Feb; 46(2):247-50. PubMed ID: 8468238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BE-29602, a new member of the Papulacandin family.
    Okada H; Nagashima M; Suzuki H; Nakajima S; Kojiri K; Suda H
    J Antibiot (Tokyo); 1996 Jan; 49(1):103-6. PubMed ID: 8609074
    [No Abstract]   [Full Text] [Related]  

  • 4. Sharpless asymmetric dihydroxylation of 5-aryl-2-vinylfurans: application to the synthesis of the spiroketal moiety of papulacandin D.
    Balachari D; O'Doherty GA
    Org Lett; 2000 Mar; 2(6):863-6. PubMed ID: 10754689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enantioselective synthesis of the papulacandin ring system: conversion of the mannose diastereoisomer into a glucose stereoisomer.
    Balachari D; O'Doherty GA
    Org Lett; 2000 Dec; 2(25):4033-6. PubMed ID: 11112636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chaetiacandin, a novel papulacandin. II. Structure determination.
    Komori T; Itoh Y
    J Antibiot (Tokyo); 1985 Apr; 38(4):544-6. PubMed ID: 3839234
    [No Abstract]   [Full Text] [Related]  

  • 7. Papulacandins, a new family of antibiotics with antifungal activity. Structures of papulacandins A, B, C and D.
    Traxler P; Fritz H; Fuhrer H; Richter WJ
    J Antibiot (Tokyo); 1980 Sep; 33(9):967-78. PubMed ID: 7440418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Papulacandins--synthesis and biological activity of papulacandin B derivatives.
    Traxler P; Tosch W; Zak O
    J Antibiot (Tokyo); 1987 Aug; 40(8):1146-64. PubMed ID: 3680026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chaetiacandin, a novel papulacandin. I. Fermentation, isolation and characterization.
    Komori T; Yamashita M; Tsurumi Y; Kohsaka M
    J Antibiot (Tokyo); 1985 Apr; 38(4):455-9. PubMed ID: 3839230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. F-10748 A1, A2, B1, B2, C1, C2, D1 and D2, novel papulacandins.
    Ohyama T; Iwadate-Kurihara Y; Hosoya T; Ishikawa T; Miyakoshi S; Hamano K; Inukai M
    J Antibiot (Tokyo); 2002 Aug; 55(8):758-63. PubMed ID: 12374387
    [No Abstract]   [Full Text] [Related]  

  • 11. A fully synthetic route to the papulacandins. Stereo-specific spiroacetalization of a C-1-arylated methyl glycoside.
    Danishefsky S; Phillips G; Ciufolini M
    Carbohydr Res; 1987 Dec; 171():317-27. PubMed ID: 3442776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Progress on studies of nikkomycin structure and some genes related to nikkomycin biosynthesis].
    Chen W; Tan HR
    Sheng Wu Gong Cheng Xue Bao; 2000 Sep; 16(5):548-50. PubMed ID: 11191754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Echinocandins and pneumocandins--a new antifungal class with a novel mode of action.
    Denning DW
    J Antimicrob Chemother; 1997 Nov; 40(5):611-4. PubMed ID: 9421307
    [No Abstract]   [Full Text] [Related]  

  • 14. Fusacandins A and B; novel antifungal antibiotics of the papulacandin class from Fusarium sambucinum. I. Identity of the producing organism, fermentation and biological activity.
    Jackson M; Frost DJ; Karwowski JP; Humphrey PE; Dahod SK; Choi WS; Brandt K; Malmberg LH; Rasmussen RR; Scherr MH
    J Antibiot (Tokyo); 1995 Jul; 48(7):608-13. PubMed ID: 7649856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validamycin H, a new pseudo-tetrasaccharide antibiotic.
    Asano N; Kameda Y; Matsui K; Horii S; Fukase H
    J Antibiot (Tokyo); 1990 Aug; 43(8):1039-41. PubMed ID: 2211355
    [No Abstract]   [Full Text] [Related]  

  • 16. Lanomycin and glucolanomycin, antifungal agents produced by Pycnidiophora dispersa. II. Structure elucidation.
    Phillipson DW; O'Sullivan J; Johnson JH; Bolgar MS; Kahle AD
    J Antibiot (Tokyo); 1992 Mar; 45(3):313-9. PubMed ID: 1577659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of the relative and absolute configuration of the dimethylmyristoyl side chain of pneumocandin B0 by asymmetric synthesis.
    Leonard WR; Belyk KM; Bender DR; Conlon DA; Hughes DL; Reider PJ
    Org Lett; 2002 Nov; 4(24):4201-4. PubMed ID: 12443058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Caspofungin. A new antimycotic agents from the echinocandin group].
    Hennemann A
    Med Monatsschr Pharm; 2001 Sep; 24(9):282-4. PubMed ID: 11584760
    [No Abstract]   [Full Text] [Related]  

  • 19. Reductive aromatization of quinols: synthesis of the C-arylglycoside nucleus of the papulacandins and chaetiacandin.
    Parker KA; Georges AT
    Org Lett; 2000 Feb; 2(4):497-9. PubMed ID: 10814360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. cps1+, a Schizosaccharomyces pombe gene homolog of Saccharomyces cerevisiae FKS genes whose mutation confers hypersensitivity to cyclosporin A and papulacandin B.
    Ishiguro J; Saitou A; Durán A; Ribas JC
    J Bacteriol; 1997 Dec; 179(24):7653-62. PubMed ID: 9401022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.